Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the antidepressant efficacy and safety of two
doses of DVS SR (25 and 50 mg/day) in the treatment of adults with Major Depressive Disorder.
The study will also assess changes in sexual function and general and functional quality of
life outcomes.